Simultaneous detection of three antineoplastic drugs on gloves by liquid chromatography with diode array detector

Brazilian Journal of Pharmaceutical Sciences

Volumn 46, Issue 4, 2010, Pages 731-740

  Alcântara, Adélia Maria Pimenta de Pádua ^a   Vitor, Ricardo Vilela ^a   Vieira, Elisabeth Pizzamiglio ^a   Martins, Isarita ^a  

^a FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

Author keywords

Antineoplastic drugs detection; Gloves toxicologial analysis; High Performance LiquidChromatography toxicologial analysis; Occupational exposure

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONITRILE; FLUOROURACIL; METHANOL; METHOTREXATE; PACLITAXEL; WATER;

ARTICLE; CONCENTRATION (PARAMETERS); DIODE ARRAY DETECTOR; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; ELECTRICAL EQUIPMENT; ELUTION; FLOW RATE; GLOVE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID LIQUID EXTRACTION; PH; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SOLID PHASE EXTRACTION; ULTRAVIOLET SPECTROSCOPY;

EID: 79956321556     PISSN: 19848250     EISSN: 21759790     Source Type: Journal    
DOI: 10.1590/s1984-82502010000400015     Document Type: Article

References (28)

1. ALCÂNTARA, A.M.P.P.; VENUTO, L.M. A; FRANÇA, A.L.F.; VIEIRA, E.P.; MARTINS, I. Liquid chromatographic method for simultaneous determination of five antineoplastic drugs. Lat. Am. J. Pharm., v.28, p.525-530, 2009.
2. ALESSIO, L.; APOSTOLI, P.; DRAICCHIO, F.; FORNI, A.; LUCCHINI, R.; MERLER, E.; PALAZZO, S.; SCARSELLI, R.; SOSSAI, D. Prevention of risks from occupational exposure to antineoplastic drugs. Consensus document. Med. Lav., v.87, p.194-200, 1996.
3. CASTIGLIA, L.; MIRAGLIA, N.; PIERI, M.; SIMONELLI, A.; BASILICATA, P.; GENOVESE, G.; GUADAGNI, R.; ACAMPORA, A.; SANNOLO, N.; SCAFARTO, M.V. Evaluation of occupational exposure to antiblastic drugs in an italian hospital oncological department. J. Occup. Health, v.50, p.46-48, 2008.
4. COE, R.A.; EARL, R.A.; JOHNSON, T.C.; LEE, J.W. Determination of 5-fluorouracil in human plasma by a simple and sensitive reversed-phase HPLC method. J. Pharm. Biomed. Anal., v.14, p.1733-1741, 1996.
5. CONNOR, T.H. Permeability of nitrile rubber, latex, polyurethane, and neoprene gloves to 18 antineoplastic drugs. Am. J. Health-Syst. Pharm., v.56, p.2450-2453, 1999.
6. INTERNACIONAL UNION OF PURE AND APPLIED CHEMISTRY. IUPAC. Harmonized guidelines for single-laboratory validation of methods of analysis-IUPAC Technical Report. Pure Appl. Chem., v.74, p.835-855, 2002.
7. LARSON, R.R.; KHAZAELI, M.B.; DILLON, H.K. Development of an HPLC method for simultaneous analysis of five antineoplastic agents. Appl. Occup. Environ. Hyg., v.18, p.109-119, 2003.
8. MARTINS, I.; APOSTOLI, P.; DELLA ROSA, H.V. Cyclophosphamide levels in sites of preparation and administration of antineoplastic drugs. Lat. Am. J. Pharm., v.27, p.217-223, 2008.
9. MICOLI, G.; TURCI, R.; ARPELLINI, M.; MINOIA, C. Determination of 5-fluorouracil in enviromental samples by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B, v.750, p.25-32, 2001.
10. MINOIA, C.; TURCI, R.; SOTTANI, C.; SCHIAVI, A.; PERBELLINI, L.; ANGELERI, S.; DRAICCHIO, F.; APOSTOLI, P. Application of high-performance liquid chromatography/ tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Commun. Mass Spectrom., v.12, p.1485-1493, 1998.
11. NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH. NIOSH Alert: preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. Cincinatti, Ohio: NIOSH, 2004. 50 p. (Publication no 2004-165).
12. O'NEIL, M.J.; HECKELMAN, P.E.; KOCH, C.B.; ROMAN, K.J. (Eds). The Merck Index: an encyclopedia of chemicals, drugs, and biologicals. 14. ed. Whitehouse Station: Merck, 2006. 3000 p.
13. REYNOLDS, J.E.F. Martindale the extra Pharmacopoeia. 31. ed. London: Royal Pharmaceutical Society, 1996. 2739p.
14. ROBERTS, S.; KHAMMO, N.; MCDONNELL, G.; SEWELL, G.J. Studies on the decontamination of surfaces exposed to cytotoxic drugs in chemoterapy workstations. J. Oncol. Pharm. Pract., v.12, p.95-104, 2006.
15. RUBINO, F.M. Separation methods for methotrexate, its structural analogues and metabolites. J. Chromatogr. B, v.764, p.217-254, 2001.
16. SCIFINDER SCHOLAR. Database. Washington DC: American Chemical Society, 2005. Version 2006. Available at: . Accessed on: 20 feb. 2009.
17. SESSINK, P.J.M.; WITTENHORST, B.C.J.; ANZION, R.B.M.; BOS, R.P. Exposure of pharmacy technicians to antineoplastic agents: reevaluation after additional protective measures. Arch. Environ. Health, v.52, p.240-244, 1997.
18. SESSINK, P.M.J.; BOER K.A.; SCHEEFHALS, A.P.H.; ANZION, R.B.M.; BOS, R.P. Occupational exposure to antineoplastic agents at several departments in a hospital. Environment contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Int. Arch. Occup. Environ. Health, v.64, p.105-112, 1992.
19. SHABIR, G.A.J. Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization. J. Chromatogr. A, v.987, p.57-66, 2003.
20. SORSA, M.; ANDERSON, D. Monitoring of occupational exposure to cytostatic anticancer agents. Mutat. Res., v.355, p.53-61, 1996.
21. SOTTANI, C.; MINOIA, C.; D'INCALCI, M.; PAGANINI, M.; ZUCCHETTI, M. High-performance liquid chromatography tandem mass spectrometry procedure with automated solid phase extraction sample preparation for the quantitative determination of paclitaxel (Taxol®) in human plasma. Rapid Commun. Mass Spectrom., v.12, p.251-255, 1998.
22. SOTTANI, C.; TURCI, R.; MICOLI, G.; FIORENTINO, M. L.; MINOIA, C. Rapid and sensitive determination of paclitaxel (taxol) in environmental samples by high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS). Rapid Comm. Mass Spectrom., v.14, p.930-935, 2000.
23. STILES, M.L.; ALLEN JR, L.V.; PRINCE, S.J. Stability of deferoxamine mesylate, floxuridine, fluorouracil, hydromorphon hydrochloride, lorazepam, midazolam hydrochloride in polypropylene infusion-pump syringes. Am. J. Health-Syst. Pharm., v.53, p.1583-1588, 1996.
24. TURCI, R.; MICOLI, G.; MINOIA, C. Determination of methotrexate in environmental samples by solid phase extraction and high performance liquid chromatography: ultraviolet or tandem mass spectrometry detection?. Rapid Commun. Mass Spectrom., v.14, p.685-691, 2000.
25. TURCI, R.; SOTTANI, C.; RONCHI, A.; MINOIA, C. Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents. Toxicol. Lett., v.134, p.57-64, 2002.
26. TURCI, R.; SOTTANI, C.; SPAGNOLI, G.; MINOIA, C. Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods. J. Chromatogr. B, v.789, p.169-209, 2003.
27. WALLEMACQ, P.E.; CAPRON, A.; VANBINST, R.; BOECKMANS, E.; GILLARD, J.; FAVIER, B. Permeability of 13 different gloves to 13 cytotoxic agents under controlled dynamic conditions. Am. J. Health-Syst. Pharm., v.63, p.547-556, 2006.
28. WILLEY, T.A.; BEKOS, E.J.; GAVER, R.C.; DUNCAN, G.F.; TAY, L.K.; BEIJNEN, J.H.; FARMEN, R.H. High-performance liquid chromatographic procedure for the quantitative determination of paclitaxel (Taxol®) in human plasma. J. Chromatogr. B, v.621, p.231-238, 1993.